Pacific Biosciences Of California Shares Outstanding 2010-2025 | PACB

Pacific Biosciences Of California shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of Shares)
2024 288
2023 254
2022 225
2021 204
2020 175
2019 153
2018 135
2017 106
2016 89
2015 76
2014 70
2013 63
2012 56
2011 54
2010 10
2009 1
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 297
2024-12-31 288
2024-09-30 273
2024-06-30 272
2024-03-31 270
2023-12-31 254
2023-09-30 255
2023-06-30 250
2023-03-31 242
2022-12-31 225
2022-09-30 225
2022-06-30 224
2022-03-31 222
2021-12-31 204
2021-09-30 215
2021-06-30 199
2021-03-31 195
2020-12-31 175
2020-09-30 167
2020-06-30 154
2020-03-31 156
2019-12-31 153
2019-09-30 153
2019-06-30 153
2019-03-31 151
2018-12-31 135
2018-09-30 135
2018-06-30 132
2018-03-31 124
2017-12-31 106
2017-09-30 116
2017-06-30 97
2017-03-31 93
2016-12-31 89
2016-09-30 92
2016-06-30 88
2016-03-31 84
2015-12-31 76
2015-09-30 80
2015-06-30 75
2015-03-31 74
2014-12-31 70
2014-09-30 71
2014-06-30 71
2014-03-31 68
2013-12-31 63
2013-09-30 66
2013-06-30 62
2013-03-31 57
2012-12-31 56
2012-09-30 56
2012-06-30 56
2012-03-31 55
2011-12-31 54
2011-09-30 54
2011-06-30 53
2011-03-31 53
2010-12-31 10
2010-09-30 1
2010-06-30 1
2010-03-31 1
2009-12-31
2009-09-30 1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.348B $0.154B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $187.241B 82.01
Thermo Fisher Scientific (TMO) United States $156.717B 18.96
Edwards Lifesciences (EW) United States $44.271B 29.03
Alcon (ALC) Switzerland $43.692B 29.53
IDEXX Laboratories (IDXX) United States $42.156B 48.44
DexCom (DXCM) United States $32.541B 50.30
IQVIA Holdings (IQV) United States $27.478B 15.39
Mettler-Toledo (MTD) United States $24.793B 29.49
STERIS (STE) Ireland $23.682B 26.08
Waters (WAT) United States $20.593B 29.06
SONOVA HOLDING (SONVY) Switzerland $18.749B 0.00
Hologic (HOLX) United States $14.391B 15.64
Sysmex ADR (SSMXY) Japan $10.512B 29.82
Penumbra (PEN) United States $9.810B 76.99
Masimo (MASI) United States $9.055B 33.40
Globus Medical (GMED) United States $8.231B 19.61
Glaukos (GKOS) United States $5.665B 0.00
Teleflex (TFX) United States $5.412B 8.93
TransMedics (TMDX) United States $4.833B 105.06
Integer Holdings (ITGR) United States $4.188B 21.94
PROCEPT BioRobotics (PRCT) United States $3.437B 0.00
LivaNova (LIVN) United Kingdom $2.546B 15.16
Veracyte (VCYT) United States $2.187B 30.69
Nihon Kohden (NHNKY) Japan $2.115B 24.25
Elekta AB (EKTAY) Sweden $1.972B 17.72
Alphatec Holdings (ATEC) United States $1.715B 0.00
Tandem Diabetes Care (TNDM) United States $1.435B 0.00
Artivion (AORT) United States $1.241B 116.20
Pulse Biosciences (PLSE) United States $1.125B 0.00
OPKO Health (OPK) United States $1.071B 0.00
Integra LifeSciences Holdings (IART) United States $0.997B 5.30
Beta Bionics (BBNX) United States $0.829B 0.00
SiBone (SIBN) United States $0.802B 0.00
IRadimed (IRMD) United States $0.763B 38.72
RxSight (RXST) United States $0.606B 0.00
Mesa Laboratories (MLAB) United States $0.570B 13.36
AVANOS MEDICAL, INC (AVNS) United States $0.570B 8.86
Delcath Systems (DCTH) United States $0.556B 0.00
OrthoPediatrics (KIDS) United States $0.537B 0.00
AxoGen (AXGN) United States $0.463B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.446B 0.00
AngioDynamics (ANGO) United States $0.443B 0.00
Treace Medical Concepts (TMCI) United States $0.388B 0.00
NeuroPace (NPCE) United States $0.388B 0.00
ClearPoint Neuro (CLPT) United States $0.360B 0.00
Semler Scientific (SMLR) United States $0.354B 9.41
908 Devices (MASS) United States $0.261B 0.00
Neuronetics (STIM) United States $0.251B 0.00
Tactile Systems Technology (TCMD) United States $0.233B 14.13
Sight Sciences (SGHT) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.216B 0.00
Anteris Technologies Global (AVR) Australia $0.185B 0.00
Biosig Technologies (BSGM) United States $0.183B 0.00
Spectral Diagnostics (EDTXF) Canada $0.177B 0.00
Inogen (INGN) United States $0.173B 0.00
CVRx (CVRX) United States $0.172B 0.00
Rapid Micro Biosystems (RPID) United States $0.165B 0.00
LENSAR (LNSR) United States $0.153B 0.00
Lucid Diagnostics (LUCD) United States $0.138B 0.00
Accuray (ARAY) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.113B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.084B 51.00
EnVVeno Medical (NVNO) United States $0.079B 0.00
InspireMD (NSPR) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.22